Company / EPS (Basic)
Sunshine Biopharma Inc. EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$7.32
FY2025
5-year range
-$351.36 / -$1.76
FY2021-FY2025
Trend
+97.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Basic) has fluctuated over the past 10 years, ranging from $-351.36 in FY2024 to $-0.01 in FY2017.
Based on SEC 10-K filings.
-7.32 in FY2025.
Declined from $-1.76 to $-7.32 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (basic) increased 97.9% year-over-year.
- Peak eps (basic) was recorded in FY2017.
- Lowest eps (basic) in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$7.32 | +97.9% |
| FY2024 | -$351.36 | -19863.6% |
| FY2023 | -$1.76 | +63.0% |
| FY2022 | -$4.76 | -74.4% |
| FY2021 | -$2.73 | -1720.0% |
| FY2020 | -$0.15 | +78.9% |
| FY2019 | -$0.71 | -3450.0% |
| FY2018 | -$0.02 | -100.0% |
| FY2017 | -$0.01 | +0.0% |
| FY2016 | -$0.01 | +66.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026